nystatin-a1 has been researched along with Endophthalmitis* in 5 studies
5 other study(ies) available for nystatin-a1 and Endophthalmitis
Article | Year |
---|---|
Fungal endophthalmitis developing in asthmatic individuals treated with inhaled corticosteroids.
Topics: Administration, Inhalation; Aged; Amphotericin B; Anti-Asthmatic Agents; Asthma; Candidemia; Candidiasis, Oral; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Glucocorticoids; Humans; Nystatin; Risk Factors | 2011 |
[Congenital candida infections].
Congenital candida infection is a rare disease, although the incidence of candida vaginitis during pregnancy is high. We report on five cases each showing patterns considered typical for candida infection. The infective agent can cause chorioamnionitis even in the presence of intact fetal membranes. An intrauterine device (IUD) has been proved to be a risk factor for a congenital candida infection. The pathogenetic significance of contamination with candida for the fetus appears to depend largely on gestational age. A premature infant with a birth-weight less than 1500 g presented with bilateral candida endophthalmitis which was cured by intravenous Fluconazole therapy. Another premature infant weighing 800 g at birth developed a systemic candida infection. The other three more mature infants had milder symptoms, two of them presented with cutaneous candidiasis. Topics: Adult; Amniocentesis; Amphotericin B; Candidiasis; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Chorioamnionitis; Drug Therapy, Combination; Endophthalmitis; Female; Fetal Membranes, Premature Rupture; Flucytosine; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Nystatin; Pregnancy | 1993 |
Endogenous Candida endophthalmitis in infants.
Two infants recovered from endogenous Candida endophthalmitis. Case 1, to the best of my knowledge, is the first reported full term neonate with this entity. Free-floating vitreous opacitis ("ballon vitréen") were found in one infant and the second infant's lesions resolved in a more conventional manner. Topics: Amphotericin B; Candidiasis; Ductus Arteriosus, Patent; Endophthalmitis; Female; Flucytosine; Humans; Infant; Infant, Newborn; Infant, Premature; Intestinal Obstruction; Intestine, Small; Male; Nystatin; Oxygen | 1980 |
Endogenous Candida endophthalmitis leading to bilateral corneal perforation.
A premature neonate developed advanced bilateral endophthalmitis before the significance of underlying Candida sepsis was appreciated. Severe endophthalmitis resulted in corneal thinning, descemetocele formation, and perforation. The infection occurred in the clinical setting of broad-spectrum antibiotic therapy and indwelling intravenous catheters. Cultures of blood and catheter tips had been positive for Candida but were not considered significant until advanced ocular infection was noted. The septic process resulted in the infant's death after systemic amphotericin B therapy was discontinued because of renal toxicity. Topics: Amphotericin B; Candidiasis; Corneal Diseases; Endophthalmitis; Eye; Humans; Infant, Newborn; Infant, Premature, Diseases; Klebsiella Infections; Male; Nystatin | 1975 |
ENDOGENOUS FUNGAL ENDOPHTHALMITIS. CLINICAL COURSE IN A SUCCESSFULLY TREATED CASE.
Topics: Amphotericin B; Candida; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Humans; Nystatin; Ophthalmology; Ophthalmoscopy; Retina; Sepsis; Vitreous Body | 1963 |